Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lykken

Showing results (141-150 of 410) with videos related to

Pageof 41
Sort By:
Oncotarget|March 12, 2016
MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancerXin Xu, Yun Zhang, Jeff Jasper, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 2014
Acute and chronic B cell depletion disrupts CD4+ and CD8+ T cell homeostasis and expansion during acute viral infection in miceJacquelyn M Lykken, David J DiLillo, Eric T Weimer, et al.
Immunity|February 28, 2016
MicroRNA-23a Curbs Necrosis during Early T Cell Activation by Enforcing Intracellular Reactive Oxygen Species EquilibriumBaojun Zhang, Si-Qi Liu, Chaoran Li, et al.
Journal of General Internal Medicine|November 6, 2023
Improving Colorectal Cancer Screening in a Regional Safety-Net Health System over a 10-Year Period: Lessons for Population HealthEthan A Halm, Rasmi G Nair, Ellen Hu, et al.
O&G Open|September 26, 2025
Accessibility of Criteria to Exit Cervical Cancer Screening at Age 65 Years in the Electronic Health RecordStephanie Alimena, Jacquelyn M Lykken, Jasmin A Tiro, et al.
International Journal of Molecular Sciences|July 2, 2021
Investigating Immune Responses to the scAAV9-<i>HEXM</i> Gene Therapy Treatment in Tay-Sachs Disease and Sandhoff Disease Mouse ModelsShalini Kot, Subha Karumuthil-Melethil, Evan Woodley, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 23, 2024
Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare SettingsDavid Cheng, Meghan L Rieu-Werden, Jacquelyn M Lykken, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthAnna L Parks, Jacquelyn M Lykken, Meghan L Rieu-Werden, et al.
JAMA Network Open|January 17, 2025
Delivering Guideline-Concordant Care for Patients With High-Risk HPV and Normal Cytologic FindingsJasmin A Tiro, Jacquelyn M Lykken, Patricia M Chen, et al.
Neurology|December 29, 2025
Risk of New Indications for Anticoagulants and Thrombolytics in People With Cognitive Impairment: Implications for Anti-Amyloid TherapyAnna L Parks, Jacquelyn M Lykken, Meghan L Rieu-Werden, et al.
Pageof 41

Showing results (141-150 of 410) with videos related to

Sort By:
Pageof 41
Oncotarget|March 12, 2016
MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancerXin Xu, Yun Zhang, Jeff Jasper, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 2014
Acute and chronic B cell depletion disrupts CD4+ and CD8+ T cell homeostasis and expansion during acute viral infection in miceJacquelyn M Lykken, David J DiLillo, Eric T Weimer, et al.
Immunity|February 28, 2016
MicroRNA-23a Curbs Necrosis during Early T Cell Activation by Enforcing Intracellular Reactive Oxygen Species EquilibriumBaojun Zhang, Si-Qi Liu, Chaoran Li, et al.
Journal of General Internal Medicine|November 6, 2023
Improving Colorectal Cancer Screening in a Regional Safety-Net Health System over a 10-Year Period: Lessons for Population HealthEthan A Halm, Rasmi G Nair, Ellen Hu, et al.
O&G Open|September 26, 2025
Accessibility of Criteria to Exit Cervical Cancer Screening at Age 65 Years in the Electronic Health RecordStephanie Alimena, Jacquelyn M Lykken, Jasmin A Tiro, et al.
International Journal of Molecular Sciences|July 2, 2021
Investigating Immune Responses to the scAAV9-<i>HEXM</i> Gene Therapy Treatment in Tay-Sachs Disease and Sandhoff Disease Mouse ModelsShalini Kot, Subha Karumuthil-Melethil, Evan Woodley, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 23, 2024
Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare SettingsDavid Cheng, Meghan L Rieu-Werden, Jacquelyn M Lykken, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthAnna L Parks, Jacquelyn M Lykken, Meghan L Rieu-Werden, et al.
JAMA Network Open|January 17, 2025
Delivering Guideline-Concordant Care for Patients With High-Risk HPV and Normal Cytologic FindingsJasmin A Tiro, Jacquelyn M Lykken, Patricia M Chen, et al.
Neurology|December 29, 2025
Risk of New Indications for Anticoagulants and Thrombolytics in People With Cognitive Impairment: Implications for Anti-Amyloid TherapyAnna L Parks, Jacquelyn M Lykken, Meghan L Rieu-Werden, et al.
Pageof 41